Literature DB >> 24168788

Safety profile of high-fluence corneal collagen cross-linking for progressive keratoconus: preliminary results from a prospective cohort study.

Zisis Gatzioufas, Olivier Richoz, Eliane Brugnoli, Farhad Hafezi.   

Abstract

PURPOSE: To investigate the effect of high-fluence corneal collagen cross-linking (CXL) with riboflavin and ultraviolet-A in the management of progressive keratoconus.
METHODS: Preliminary results from a prospective cohort study. Seven eyes from 7 patients with progressive keratoconus subjected to CXL were included. CXL was performed as a standard epithelium-off procedure, irradiating with high-fluence settings (18 mW/cm(2) for 5 minutes). Endothelial cell density (ECD), speed of postoperative epithelial healing, maximal and average keratometric readings (Kmax and Kmean, respectively) of the anterior corneal surface, and corrected distance visual acuity (CDVA) were evaluated preoperatively and at 1 and 6 months after CXL. One-way analysis of variance was applied for statistical analysis. P values less than .05 were considered significant.
RESULTS: ECD did not change significantly postoperatively and complete epithelial healing occurred in all eyes within 96 hours postoperatively. No morphological alterations in the corneal limbus were observed. Kmax, Kmean, and CDVA showed no significant changes at 1 and 6 months postoperatively. No complications were observed postoperatively.
CONCLUSIONS: Although the preliminary results are not sufficient for a valid evaluation of the biomechanical effect and the overall safety profile of high-fluence CXL in vivo, they demonstrate that CXL at 18 mW/cm(2) for 5 minutes affects neither endothelial cell density nor the speed of epithelial healing, an indirect indicator of limbal stem cell function. Copyright 2013, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24168788     DOI: 10.3928/1081597X-20131023-03

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  14 in total

1.  Is accelerated corneal collagen cross-linking for keratoconus the way forward? Yes.

Authors:  M Tsatsos; C MacGregor; N Kopsachilis; D Anderson
Journal:  Eye (Lond)       Date:  2014-05-02       Impact factor: 3.775

2.  Corneal crosslinking (CXL) with 18-mW/cm2 irradiance and 5.4-J/cm2 radiant exposure-early postoperative safety.

Authors:  Isaak Fischinger; Theo G Seiler; Karthiga Santhirasegaram; Moritz Pettenkofer; Chris P Lohmann; Daniel Zapp
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-17       Impact factor: 3.117

3.  Transepithelial accelerated corneal collagen cross-linking with higher oxygen availability for keratoconus: 1-year results.

Authors:  Ling Sun; Meng Li; Xiaoyu Zhang; Mi Tian; Tian Han; Jing Zhao; Xingtao Zhou
Journal:  Int Ophthalmol       Date:  2017-11-07       Impact factor: 2.031

4.  Accelerated, Pulsed Collagen Cross-Linking versus the Dresden Protocol in Keratoconus: A Case Series.

Authors:  Nikolaos Dervenis; Panagiotis Dervenis; Nikolaos Dragoumis; Andreas Papandroudis; Zachos Zachariadis; Miltos Balidis
Journal:  Med Princ Pract       Date:  2020-02-04       Impact factor: 1.927

5.  Pharmacologic alternatives to riboflavin photochemical corneal cross-linking: a comparison study of cell toxicity thresholds.

Authors:  MiJung Kim; Anna Takaoka; Quan V Hoang; Stephen L Trokel; David C Paik
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-10       Impact factor: 4.799

Review 6.  Corneal Cross-Linking for Pediatric Keratcoconus Review.

Authors:  Claudia Perez-Straziota; Ronald N Gaster; Yaron S Rabinowitz
Journal:  Cornea       Date:  2018-06       Impact factor: 2.651

7.  Comparison of modified corneal cross-linking with intrastromal voriconazole for the treatment of fungal corneal ulcer.

Authors:  Yingxin Chen; Xingya Miao; Minghong Gao; Lixin Song
Journal:  Exp Ther Med       Date:  2021-05-21       Impact factor: 2.447

8.  One-year outcomes of conventional and accelerated collagen crosslinking in progressive keratoconus.

Authors:  Vanissa W S Chow; Tommy C Y Chan; Marco Yu; Victoria W Y Wong; Vishal Jhanji
Journal:  Sci Rep       Date:  2015-09-25       Impact factor: 4.379

Review 9.  Corneal stromal demarcation line after collagen cross-linking in corneal ectatic diseases: a review of the literature.

Authors:  Leopoldo Spadea; Emanuele Tonti; Enzo Maria Vingolo
Journal:  Clin Ophthalmol       Date:  2016-09-19

10.  A Prospective, Comparative, Clinical Study to Evaluate the Safety and Efficacy of Two Different 0.1% Riboflavin Solutions Used in Collagen Crosslinking Treatment for Patients with Keratoconus.

Authors:  Sheetal Brar; Sri Ganesh; Shilpa S Reddy; Nagesh Bn; Dhwni Shahanand
Journal:  Clin Ophthalmol       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.